Letters Government undermining of NICE

The ABPI’s response to news story on leading academics’ condemnation of government undermining of NICE

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2649 (Published 19 May 2015) Cite this as: BMJ 2015;350:h2649
  1. Alison Clough, ABPI acting chief executive and ABPI executive director—commercial1
  1. 1Association of the British Pharmaceutical Industry (ABPI), London SW1E 6QT, UK
  1. aclough{at}abpi.org.uk

The allegations in the news story “Leading academics condemn government undermining of NICE,” on the Maynard and Bloom paper published in the Journal of the Royal Society of Medicine, are misleading and, in many cases, incorrect.1

Firstly, the government does not subsidise the drug industry. Under the five year voluntary Pharmaceutical Price Regulation Scheme (PPRS) agreed with the …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe